nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromodiphenhydramine—HRH1—Histamine receptors—HRH3—attention deficit hyperactivity disorder	0.128	0.155	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Monoamine GPCRs—ADRA2C—attention deficit hyperactivity disorder	0.035	0.0422	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Monoamine GPCRs—DRD5—attention deficit hyperactivity disorder	0.0343	0.0414	CbGpPWpGaD
Bromodiphenhydramine—SLC47A1—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.0334	0.0403	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Amine ligand-binding receptors—ADRA2C—attention deficit hyperactivity disorder	0.0294	0.0355	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Amine ligand-binding receptors—DRD5—attention deficit hyperactivity disorder	0.0288	0.0348	CbGpPWpGaD
Bromodiphenhydramine—SLC47A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—attention deficit hyperactivity disorder	0.0256	0.0309	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Monoamine GPCRs—HTR1B—attention deficit hyperactivity disorder	0.0208	0.0251	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Amine ligand-binding receptors—HRH3—attention deficit hyperactivity disorder	0.02	0.0241	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Monoamine GPCRs—DRD1—attention deficit hyperactivity disorder	0.0193	0.0233	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Monoamine GPCRs—DRD3—attention deficit hyperactivity disorder	0.0187	0.0226	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.0184	0.0222	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.0181	0.0219	CbGpPWpGaD
Bromodiphenhydramine—Captodiame—DRD3—attention deficit hyperactivity disorder	0.0175	0.102	CrCbGaD
Bromodiphenhydramine—HRH1—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.0174	0.0211	CbGpPWpGaD
Bromodiphenhydramine—SLC47A1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.017	0.0205	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.0169	0.0204	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.0162	0.0196	CbGpPWpGaD
Bromodiphenhydramine—SLC47A1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.0162	0.0195	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.0157	0.019	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.0154	0.0186	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.0152	0.0184	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.0142	0.0172	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.0131	0.0158	CbGpPWpGaD
Bromodiphenhydramine—Diphenylpyraline—SLC6A3—attention deficit hyperactivity disorder	0.0126	0.0735	CrCbGaD
Bromodiphenhydramine—HRH1—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.0118	0.0143	CbGpPWpGaD
Bromodiphenhydramine—SLC47A1—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.0116	0.014	CbGpPWpGaD
Bromodiphenhydramine—Doxepin—ADRA2C—attention deficit hyperactivity disorder	0.0111	0.0647	CrCbGaD
Bromodiphenhydramine—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—attention deficit hyperactivity disorder	0.01	0.0121	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.00995	0.012	CbGpPWpGaD
Bromodiphenhydramine—Chlorphenamine—SLC6A3—attention deficit hyperactivity disorder	0.00735	0.0427	CrCbGaD
Bromodiphenhydramine—Fluoxetine—SLC6A4—attention deficit hyperactivity disorder	0.00718	0.0418	CrCbGaD
Bromodiphenhydramine—Atomoxetine—HTR1B—attention deficit hyperactivity disorder	0.00683	0.0397	CrCbGaD
Bromodiphenhydramine—HRH1—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00675	0.00815	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00667	0.00805	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00661	0.00798	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00656	0.00793	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00636	0.00768	CbGpPWpGaD
Bromodiphenhydramine—Benzphetamine—SLC6A3—attention deficit hyperactivity disorder	0.00622	0.0362	CrCbGaD
Bromodiphenhydramine—Atomoxetine—SLC6A3—attention deficit hyperactivity disorder	0.00617	0.0359	CrCbGaD
Bromodiphenhydramine—Benzphetamine—ADRA2A—attention deficit hyperactivity disorder	0.0061	0.0355	CrCbGaD
Bromodiphenhydramine—Cyclobenzaprine—HTR2A—attention deficit hyperactivity disorder	0.00604	0.0351	CrCbGaD
Bromodiphenhydramine—SLC47A1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.0059	0.00713	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00578	0.00698	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00566	0.00684	CbGpPWpGaD
Bromodiphenhydramine—Fluoxetine—HTR2A—attention deficit hyperactivity disorder	0.00552	0.0321	CrCbGaD
Bromodiphenhydramine—Chlorphenamine—SLC6A4—attention deficit hyperactivity disorder	0.00549	0.032	CrCbGaD
Bromodiphenhydramine—Promazine—DRD4—attention deficit hyperactivity disorder	0.00536	0.0312	CrCbGaD
Bromodiphenhydramine—Doxepin—ADRA2A—attention deficit hyperactivity disorder	0.00474	0.0276	CrCbGaD
Bromodiphenhydramine—Atomoxetine—SLC6A4—attention deficit hyperactivity disorder	0.00462	0.0268	CrCbGaD
Bromodiphenhydramine—HRH1—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00458	0.00553	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00457	0.00551	CbGpPWpGaD
Bromodiphenhydramine—Promazine—DRD1—attention deficit hyperactivity disorder	0.00454	0.0264	CrCbGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.0044	0.00532	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00431	0.00521	CbGpPWpGaD
Bromodiphenhydramine—HRH1—IL-4 Signaling Pathway—EP300—attention deficit hyperactivity disorder	0.00423	0.00511	CbGpPWpGaD
Bromodiphenhydramine—Promazine—ADRA2A—attention deficit hyperactivity disorder	0.00422	0.0245	CrCbGaD
Bromodiphenhydramine—Amitriptyline—HTR1B—attention deficit hyperactivity disorder	0.00414	0.0241	CrCbGaD
Bromodiphenhydramine—Amitriptyline—DRD3—attention deficit hyperactivity disorder	0.00402	0.0234	CrCbGaD
Bromodiphenhydramine—HRH1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00401	0.00484	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00393	0.00474	CbGpPWpGaD
Bromodiphenhydramine—Imipramine—SLC6A3—attention deficit hyperactivity disorder	0.00377	0.0219	CrCbGaD
Bromodiphenhydramine—HRH1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00372	0.0045	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00371	0.00448	CbGpPWpGaD
Bromodiphenhydramine—Amitriptyline—ADRA2A—attention deficit hyperactivity disorder	0.00367	0.0213	CrCbGaD
Bromodiphenhydramine—Doxepin—SLC6A4—attention deficit hyperactivity disorder	0.00362	0.021	CrCbGaD
Bromodiphenhydramine—HRH1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00361	0.00436	CbGpPWpGaD
Bromodiphenhydramine—Doxepin—DRD2—attention deficit hyperactivity disorder	0.0036	0.0209	CrCbGaD
Bromodiphenhydramine—Atomoxetine—HTR2A—attention deficit hyperactivity disorder	0.00355	0.0206	CrCbGaD
Bromodiphenhydramine—HRH1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00354	0.00428	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.0035	0.00423	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00343	0.00414	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00337	0.00407	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00326	0.00394	CbGpPWpGaD
Bromodiphenhydramine—Promazine—DRD2—attention deficit hyperactivity disorder	0.0032	0.0186	CrCbGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00319	0.00385	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00309	0.00373	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00304	0.00367	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.003	0.00362	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00299	0.00361	CbGpPWpGaD
Bromodiphenhydramine—HRH1—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.00296	0.00357	CbGpPWpGaD
Bromodiphenhydramine—Imipramine—SLC6A4—attention deficit hyperactivity disorder	0.00282	0.0164	CrCbGaD
Bromodiphenhydramine—Imipramine—DRD2—attention deficit hyperactivity disorder	0.0028	0.0163	CrCbGaD
Bromodiphenhydramine—Amitriptyline—SLC6A4—attention deficit hyperactivity disorder	0.0028	0.0163	CrCbGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00279	0.00337	CbGpPWpGaD
Bromodiphenhydramine—Amitriptyline—DRD2—attention deficit hyperactivity disorder	0.00278	0.0162	CrCbGaD
Bromodiphenhydramine—Doxepin—HTR2A—attention deficit hyperactivity disorder	0.00278	0.0162	CrCbGaD
Bromodiphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.00264	0.00319	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00261	0.00316	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00249	0.003	CbGpPWpGaD
Bromodiphenhydramine—Promazine—HTR2A—attention deficit hyperactivity disorder	0.00247	0.0144	CrCbGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00244	0.00294	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00243	0.00293	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00235	0.00284	CbGpPWpGaD
Bromodiphenhydramine—SLC22A6—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00232	0.0028	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00231	0.00279	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00228	0.00276	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00228	0.00276	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00226	0.00273	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00221	0.00267	CbGpPWpGaD
Bromodiphenhydramine—Imipramine—HTR2A—attention deficit hyperactivity disorder	0.00216	0.0126	CrCbGaD
Bromodiphenhydramine—Amitriptyline—HTR2A—attention deficit hyperactivity disorder	0.00215	0.0125	CrCbGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00213	0.00257	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00199	0.0024	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00196	0.00236	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00169	0.00204	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00155	0.00188	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00153	0.00185	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00149	0.0018	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00148	0.00178	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00137	0.00166	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00134	0.00162	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00133	0.00161	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00133	0.00161	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00131	0.00158	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00131	0.00158	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00129	0.00156	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00128	0.00155	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00125	0.00151	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00121	0.00146	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.0012	0.00145	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00119	0.00143	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00117	0.00142	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00109	0.00132	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000906	0.00109	CbGpPWpGaD
Bromodiphenhydramine—HRH1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000842	0.00102	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000792	0.000957	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000765	0.000924	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000736	0.000889	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000713	0.000861	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000701	0.000847	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000692	0.000836	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000645	0.000779	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000452	0.000546	CbGpPWpGaD
Bromodiphenhydramine—HRH1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000239	0.000289	CbGpPWpGaD
